Skip to content

Clinical trials

Phase 1/2 Glioblastoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 1/2 Clear all

281 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200012
20016
20029
20031
20045
20058
20069
20077
20086
200911
201014
201111
20129
201311
20148
20158
201614
201712
201814
20199
202013
202111
202212
202315
202410
20258
202615

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed131
Recruiting46
Terminated36
Active, not recruiting23
Unknown status23
Not yet recruiting10
Withdrawn8
Suspended3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)25
M.D. Anderson Cancer Center9
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins8
New Approaches to Brain Tumor Therapy Consortium7
Northwell Health6
Novartis Pharmaceuticals4
Alliance for Clinical Trials in Oncology3
Assistance Publique - Hôpitaux de Paris3
Duke University3
Eli Lilly and Company3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma281
Brain Neoplasms93
Gliosarcoma78
Glioma73
Astrocytoma60
Central Nervous System Neoplasms47
Oligodendroglioma34
Neoplasms20
Recurrence15
Carcinoma, Non-Small-Cell Lung13

Trials

Showing 76 to 100 of 281. Each trial links to its page on Pharma Observatory.

181 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.